SEC Form 4 · accession 0001179110-16-031774
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Hirschhorn
Officer — Executive VP, COO and CFO
Period of report
Nov 15, 2016
Accepted (ET)
Nov 17, 2016 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 15, 2016 | S | 5,000 | $16.82 | D | 258,387 | D | |
| Common StockF2 | Nov 16, 2016 | S | 5,000 | $17.55 | D | 253,387 | D | |
| Common Stock | Nov 16, 2016 | M | 7,500 | $1.07 | A | 260,887 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $1.07 | Nov 16, 2016 | M | 7,500 | D | — | Dec 31, 2022 | Common Stock | 7,500 | 25,297 | D |
Explanation of responses
- F1Represents the weighted average price of transactions ranging from $16.55 to $16.90. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2Represents the weighted average price of transactions ranging from $17.50 to $17.70. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The option vested as to 25% of the shares on December 31, 2013. The remainder of the shares vest in 36 equal monthly installments.